Compliance with coronavirus measures requires attention Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms decreased in the weeks leading up to the Cabinet’s recent press conference.
RIVM recommends limiting number of e-cigarettes flavourings to 23 with tobacco taste only The government wishes to make e-cigarettes less attractive, in particular for young people.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
Menthol facilitates inhalation of tobacco smoke, even when you cannot taste it Even when menthol cannot be tasted, the substance makes it easier to inhale tobacco smoke. This way, menthol makes smoking more attractive for young and novice smokers who are not yet used to inhaling sharp, pungent tobacco smoke.
Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Policy on coronavirus measures causes friction, but compliance is still high for now Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.
Last winter’s flu epidemic was short and mild. And then COVID-19 arrived. The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.
Compliance with coronavirus measures has improved Autumn 2020 saw a strong surge in the number of people who tested positive for COVID-19.
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.